Sinotruk (Hong Kong) Limited announced the resignation of Dr. Lin Zhijun as an independent non-executive Director, the chairman of the audit committee of the Company and a member of the remuneration committee of the Company, all with effect from 12 March 2024, due to changes in the operational management and development requirements of the Company. The board appointed Dr. Liu Xiaolun as an independent non-executive Director, the chairman of the Audit Committee and a member of the Remuneration Committee with effect from 12 March 2024. Dr. Liu Xiaolun, aged 52, holds a doctoral degree in enterprise management (corporate governance direction) and is a Chinese Certified Public Accountant (non-practicing).

He is currently a lecturer, an associate professor, and the responsible professor of the risk management and internal control programme at Beijing National Accounting Institute. Dr. Liu has previously served as a senior auditor of Arthur Andersen · Hua Qiang Certified Public Accountants and a senior auditor at the Beijing office of Price Waterhouse (now known as PricewaterhouseCoopers). He has also served as an independent director of China Transinfo Technology Co.

Ltd. (whose shares are listed on the Shenzhen Stock Exchange, stock code: 002373), Guangdong Highsun Group Co. Ltd. (whose shares are listed on the Shenzhen Stock Exchange, stock code: 000861), and INKON Life Technology Co. Ltd. (whose shares are listed on the Shenzhen Stock Exchange, stock code: 300143).

Dr. Liu currently serves as an independent director of Hundsun Technologies Inc. (whose shares are listed on the Shanghai Stock Exchange, stock code: 600570) and Jiangsu Bioperfectus Technologies Co. Ltd.